Skip to main content
About
Toggle submenu
About
Our story
Our leaders
Connect
Send a Message
Our Offices
Solutions
Toggle submenu
Solutions
Life Sciences Commercialization
Value & Access
Strategic Consulting
Envision Medical Communications
JAPAC
ProScribe is the most internationally recognized and regionally respected medical communication company in the Asian-Pacific region.
Connect
Send a Message
Our Offices
Technology
Toggle submenu
Technology
Technologies
Industry-leading technology-enabled strategic solutions
EnvisionOne
New, superior-in-class SaaS platform to elevate and synchronize medical information, medical communications, and improve outcomes
iEnvision
Medical affairs workflow platform
EnvisionOne Vantage
Benchmarking software to optimize publication strategies through data-driven insights
EnvisionOne Insights
A unified data & analytics solution for medical affairs
OKRA.ai
Artificial intelligence built for life sciences
Connect
Send a Message
Our Offices
News & Events
Careers
Toggle submenu
Careers
Life at Envision
Benefits at Envision
Open Opportunities
Login
Join our Talent Community
FAQs
Connect
Send a Message
Our Offices
social
Toggle submenu
Connect
Send a Message
Our Offices
Connect
Send a Message
Our Offices
Connect
Toggle submenu
Connect
Send a Message
Our Offices
NEWS & EVENTS
Stay informed
about Envision's
news, events, and industry insights
FILTER
- Any -
Appointments
Thought Leadership
Acquisitions
Min
Max
News
AI-powered real-world evidence: Strategically enhancing value and access
Aug. 22. 2024
News
Harnessing the power of process: Turning medical insights into action
Aug. 21. 2024
News
Empowering people to drive medical affairs performance with AI
Aug. 14. 2024
News
Redefining Value, Redefining Cost
Harnessing Cost-Value in Life Sciences Through Technology and Innovation
Aug. 13. 2024
News
Unlocking medical affairs insights with a game-changing AI platform
Aug. 7. 2024
News
The AI evolution: Medical communications in the digital age
Aug. 5. 2024
News
Medical affairs: The power behind redefining commercialization
Aug. 2. 2024
Pagination
Previous page
‹
Page
1
Page
2
Current page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
…
Next page
›